CND Life Sciences is a life sciences company that develops an evidence-based tool for detecting neurodegenerative diseases.
CND Life Sciences has raised $13.5M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
CND Life Sciences's investors include LabCorp, Michael J. Fox Foundation, Vilas Ventures, BlueStone Venture Partners, MBX Capital.
CND Life Sciences is headquartered in Scottsdale, United States.
CND Life Sciences is a life sciences company that develops an evidence-based tool for detecting neurodegenerative diseases.
CND Life Sciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CND Life Sciences — Funding & Investors." VCBacked, May 1, 2025, https://www.vcbacked.co/company/cnd-life-sciences. Accessed July 19, 2026.
VCBacked. (2025). CND Life Sciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/cnd-life-sciences
{{cite web |title=CND Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/cnd-life-sciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated